Forward Therapeutics, Inc. is a promising player in the Health Care industry, dedicated to revolutionizing immunology drug development. Founded in 2022, the company has swiftly gained attention with its commitment to creating impactful therapies. Attracting significant attention from investors, the most recent $50.00M Series A funding round led by RA Capital Management, OrbiMed, and BVF Partners on 08 November 2023 indicates growing confidence in the company's potential. As the United States-based Forward Therapeutics, Inc. continues to push the boundaries of small molecule biotech, its future prospects are certainly worth tracking.
No recent news or press coverage available for Forward Therapeutics, Inc..